PROB.ST Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 10:32):

Stats
Today's Volume	170.00
Average Volume	887.00
Market Cap	2.38B
EPS	SEK0 ( 2024-04-23 )
Next earnings date	( SEK0 ) 2024-07-16
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	141.22
ATR14	SEK2.42 (1.16%)

Probi AB (publ) Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Probi AB (publ) Financials

Annual	2023
Revenue:	SEK627.69M
Gross Profit:	SEK220.21M (35.08 %)
EPS:	SEK1.480

FY	2023
Revenue:	SEK627.69M
Gross Profit:	SEK220.21M (35.08 %)
EPS:	SEK1.480

FY	2022
Revenue:	SEK618.29M
Gross Profit:	SEK255.45M (41.32 %)
EPS:	SEK3.57

FY	2021
Revenue:	SEK658.18M
Gross Profit:	SEK288.01M (43.76 %)
EPS:	SEK7.30

Financial Reports:

No articles found.

Probi AB (publ)

Probi AB (publ) researches, develops, manufactures, markets, and sells probiotics for health, pharmaceutical, and food companies. The company conducts research primarily in the fields of gastrointestinal health, digestive health, immune health, bone health, and iron absorption, as well as children's, women's, and senior health. It provides dietary supplement, and food and beverage products in the form of capsules, tablets and spheres, chewable tablets, powder, fruit drinks, shots, carbonated beverages, and recovery drinks. The company sells its products approximately in 40 countries worldwide. It has a collaboration with Örebro University for research into exploration needle free vaccines; and a collaboration with La Trobe University to conduct a clinical trial to investigate the effect of Probi Osteo in an Australian women. The company was incorporated in 1991 and is headquartered in Lund, Sweden. Probi AB (publ) is a subsidiary of Symrise AG.